谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

3MO Amivantamab Plus Chemotherapy Vs Chemotherapy in EGFR-mutant Advanced NSCLC after Progression on Osimertinib: A Post-Progression Analysis of MARIPOSA-2

R.D. Gentzler,A. Spira,B. Melosky,S. Owen, T. Burns,E. Massarelli, M. Nagasaka, B. Fang,R.E. Sanborn, O.G. Arrieta Rodriguez, C. Card,F. Cappuzzo,K. Xia, P-L. Chu, S. Shah,B. Diorio, A. Garvin,P. Mahadevia,J.M. Bauml,K. Reckamp

ESMO Open（2024）

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要